Navigation Links
Cearna Appoints Mark Chenoweth as Director of Sales for the Company’s Facial Plastic Surgery Recovery Products
Date:3/26/2013

Chicago, IL (PRWEB) March 26, 2013

Mark E. Chenoweth has joined Cearna, Inc. as director of sales. Chenoweth will oversee Cearna’s national sales team for OcuMend™, a healing gel pad designed to reduce a patient’s recovery time from eye (blepharoplasty) and nose (rhinoplasty) plastic surgery by five to seven days. He will also have sales responsibility for the Chicago market. In addition, Chenoweth will be instrumental in the launch of the company’s future surgery and trauma recovery products.

Chenoweth has more than 17 years’ experience as a successful sales and sales management professional with strong expertise in business development within the medical industry. With his extensive knowledge and strong relationships in multiple surgical specialties including neurosurgery, plastic and reconstructive surgery, otolaryngology, ophthalmology and oral maxillofacial surgery, Chenoweth has developed continuous records of achievement generating revenues and improving profitability in a rapid-growth, highly competitive medical industry. He has consistently created and implemented new strategies to penetrate accounts and expand market share. Chenoweth has an innate ability to excel in roles that are evolving and largely undefined.

“We are pleased to have Mark join the Cearna team,” states Dr. Josephine Polich, founder and CEO for Cearna, Inc. “The experience and relationships Mark has within the medical industry and especially the plastic surgery market will be invaluable as we introduce additional products into this marketplace.”

Prior to joining Cearna, Chenoweth was vice president of sales & marketing at Kelyniam Global, Inc., a start-up medical device company, where he organized and developed the launch of a line of customized cranial and craniofacial implants. Chenoweth served as strategic account manager for Stryker Craniomaxillofacial where he developed sales and marketing strategies for the sales organization, assisted in the implementation and product launch of a line of craniofacial implants, and was responsible for a $20 million revenue goal. As the central region sales manager at Porex Surgical, he successfully led a team of both direct and independent reps covering 26 states. The leadership and mentoring skills he provided the sales team resulted in growth in both existing base business as well as new territory revenue.

Chenoweth received his Bachelor of Science degree in Business Marketing with high distinction from Northern Illinois University. He currently resides in Joliet, IL.

Founded in 2010 by Dr. Josephine Polich, Cearna, Inc. changes the way patients recover from plastic surgery by getting them back to their work and life faster. The company is engaged in the research, development and commercialization of surgery and trauma recovery products with a mission to help people recover faster by reducing bruising, swelling and pain. For more information about Cearna and its products, visit http://www.cearna.com or call 630-740-4580.

Read the full story at http://www.prweb.com/releases/Plastic_Surgery_Recovery/Cosmetic_Facial_Surgery/prweb10524536.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Healthesystems Appoints Dr. Robert L. Goldberg as Chief Medical Officer
2. ProvidaStaff, LLC Appoints a New Account Manager and Marketing Administrator to Keep Up with Demand for Healthcare Services
3. AxoGen, Inc. Appoints Shawn McCarrey as Vice President of Sales
4. U.N. Secretary-General Appoints Ray Chambers as His First Special Envoy for the Financing of the Health-Related Millennium Development Goals
5. Private Real Estate Investment Firm, Cohen Asset Management, Inc., Appoints Senior Vice President of Asset Management for East Coast
6. Dynarex Corporation Appoints a New National Sales Manager to Lead their Sales Organization
7. PaloDEx Appoints Brian Broncatti to the Position of Vice President North America
8. Life Support Technologies Group Appoints Edward Golembe, MD as Co-Clinical Director
9. Life Support Technologies Group Appoints Scott Gorenstein, MD as Co-Clinical Director
10. EPC Group Appoints Industry Veteran to Lead Development Practice Expansion
11. Eagle Village Appoints Mike Mischley and Dani Montini to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology: